Navigation Links
Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy

Positive interim results prompt request for meeting with FDA

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that interim results of its phase II/III trial comparing CPOP-R, in which pixantrone is substituted for doxorubicin in standard CHOP-R first-line treatment of patients with aggressive non-Hodgkin's lymphoma (NHL), resulted in essentially all patients on both arms achieving a major objective anti-tumor response (complete response or partial response). The preliminary results showed that patients who received pixantrone had a reduction in severe (grade 3/4) side effects when compared to patients treated with standard doxorubicin-based therapy. The Company intends to report data from this trial, known as RAPID, at the American Society of Hematology (ASH) annual meeting in December.

Despite pixantrone patients receiving more treatment cycles, a three-fold reduction in the incidence of severe heart damage (LVEF decline >15 percent) was seen as well as clinically significant reductions in infections and thrombocytopenia. In addition a significant reduction in febrile neutropenia was also observed. Febrile neutropenia is a life-threatening complication of chemotherapy which often requires hospitalization and antibiotic therapy and may lead to death from infection while the patient's infection-fighting white blood cells are low due to neutropenia. The RAPID study is expected to complete enrollment in 2008.

"We are excited by these results demonstrating that pixantrone is living up to the promise of preventing the severe cardiac damage that accompanies the use of standard doxorubicin treatment while retaining the potent anti-lymphoma activity of this class of drug," said James A. Bianco, M.D., President and CEO of CTI. "Pending results from this and other studies, these findings could have major implications for treating patients with breast cancer, lym
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
4. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
5. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
6. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
7. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
10. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
11. Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
Post Your Comments:
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Global Suture ... The Global Suture Industry Report 2015 ... current state of the suture industry. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/6/2015)... KENNEBUNK, Maine , May 6, 2015  Membership ... 2014, according to a Healthcare Business Strategy report ... plans, also known as Medigap or Med Supp ... December 31, 2014, a 5.2% increase from 2013. ... plans increased by 551,135 covered lives.  Though UnitedHealth ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rd24gk/chromatography ... "Chromatography (Instruments and Reagents) Global Market - Forecast ... Chromatography is an analytical technique, a method ... complex mixture by differential movement through a two ... considered chromatography as an esoteric art, which mainly ...
Breaking Medicine Technology:Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2
... , SAN FRANCISCO, Nov. 4 VIA Pharmaceuticals, Inc. ... the development of compounds for the treatment of cardiovascular ... Senior Vice President Research & Development will present "VIA-3196, ... in the Abstract Oral Session on Novel Biological Mechanisms ...
... CVS Caremark (NYSE: CVS ) today announced ... SVP, Marketing for its pharmacy benefit management business. ... Jack Bruner, who is transitioning to the new role ... http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , Greer brings twenty years ...
Cached Medicine Technology:VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 4Company Appoints New SVP, Marketing for PBM Business 2
(Date:5/6/2015)... May 06, 2015 Experienced Vancouver air ... recently announced that they will now conduct their cooling ... complexes in addition to commercial and residential units. Strata ... require a lot of technical knowledge as well as ... an installation we will take away any old air ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Canton Group ... Ravens for the 6th annual charity softball game. The ... M & T Bank Stadium. Past years guests include Joe ... Tickets are still on sale if you are ... for local non-profit organizations, such as SOAR Baltimore ...
(Date:5/6/2015)... The Beryl Institute announces the publication of ... Journal (PXJ), an international, open access, peer-reviewed journal focused ... patient experience. The second volume of PXJ supports the ... align the voices engaged and provides the space for ... with The Beryl Institute, Volume 2, Issue 1 includes ...
(Date:5/6/2015)... 2015 “ SideChef ” was featured on NewsWatch ... the latest and coolest applications on the market for iOS, Android, ... conducted the app review and shared with viewers how this application ... when to be a good navigator people had to know how ... everyone is a master navigator. Well what if people could “GPS” ...
(Date:5/6/2015)... May 06, 2015 Inversion Studios, ... in yoga and Pilates classes, provides personalized individual ... products, starting with its new Pilates Ring magic ... of becoming leaner, stronger, more centered and graceful, ... a fresh venue to healthy fitness through yoga ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... Autism Speaks, the world,s leading autism science and advocacy ... to immediately develop a new, coordinated strategy to take on ... in the wake of a new report from the U.S. ... diagnosed in a staggering 1 in every 88 American children. ...
... Island Hospital physicians identified six cases of accidental ingestion ... removal. The paper calls attention to the need for the ... It is published in the American Journal of Roentgenology ... David Grand, M.D., a radiologist in the diagnostic imaging ...
... -- A drink or two per day may help lower a ... attack, a new study suggests. The research, which appears online ... than 1,800 American men who survived a first heart attack between ... During that time, 468 of the men died. Men who ...
... , MONDAY, March 26 (HealthDay News) -- For better health, ... spend 11 or more hours a day sitting are 40 ... regardless of how physically active they are otherwise, researchers say. ... 45 and older, Australian researchers found that mortality risks spike ...
... funded by the World Health Organization (WHO) estimates that ... (HEV) genotypes 1 and 2 across 9 world regions ... issue of Hepatology , a journal published by ... Study of Liver Diseases, there were 3.4 million symptomatic ...
... -- The two-and-a-half-year TARA OCEANS expedition finishes on 31 March ... completes a journey of 60 000 miles across all the ... largest ecosystem on the planet, reports Eric Karsenti in an ... "Life and evolution started in the oceans, yet we know ...
Cached Medicine News:Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 3Health News:Rhode Island Hospital study identifies the danger of grill brushes 2Health News:Moderate Drinking Might Help Men Live Longer After Heart Attack 2Health News:Too Much Sitting Can Kill You, Study Suggests 2Health News:Too Much Sitting Can Kill You, Study Suggests 3Health News:Over 20 million individuals infected with hepatitis E in Asia and Africa 2Health News:TARA OCEANS completes 60,000-mile journey to map marine biodiversity 2
... SV stereomicroscopes are of ... Thanks to their mature ... adapt to the job ... an advantage which users ...
... SV stereomicroscopes are of the ... their mature modular design they ... in hand. This is an ... routine applications will appreciate, not ...
The SZX9 is one of the top research stereo microscopes in the Olympus line. It has the largest zoom range of any of our stereo microscopes....
Fixed Versatility - With a diverse selection of body tubes, stands, lighting techniques and Nikon's world-renowned optics, this modular microscope can be configured to fit nearly any application....
Medicine Products: